Table 1 Characterization of Animal Groups

From: Association of Spasmolytic Polypeptide–Expressing Metaplasia with Carcinogen Administration and Oxyntic Atrophy in Rats

 

Group

 

I

II

III

IV

V

VI

 

Number of cases

7

5

2

3

6

4

 

Gastritis cystica profunda

0%

0%

50%

67%

67%

50%

p = 0.0033

Intestinal metaplasia

0%

0%

0%

0%

17%

25%

ns

Adenocarcinoma

0%

0%

0%

0%

17%

50%

p = 0.041

SPEM

0%

0%

0%

0%

50%

100%

p = 0.0001

PCNA-labeling

MG

MG

MG

ED

Dual

Dual

 
  1. SPEM, spasmolytic polypeptide expressing metaplasia; MG, physiologic midgland zone; Dual, midgland and deep zone staining; ED, early dual staining; ns, not significant.